Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
entecavir, Quantity: 1 mg
Arrotex Pharmaceuticals Pty Ltd
Entecavir
Tablet
Excipient Ingredients: lactose monohydrate; hyprolose; crospovidone; magnesium stearate; titanium dioxide; iron oxide red; microcrystalline cellulose; macrogol 8000; copovidone; hypromellose
Oral
30
(S4) Prescription Only Medicine
Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.
Visual Identification: Pink colored, triangular shaped film coated tablets, engraved 'APO' on one side and '1' over 'ENT' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Registered
2016-03-10